Erratum: paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer (ACS Appl. Mater. Interfaces (2016) 8:7 (4368-4377) DOI: 10.1021/acsami.5b09340);Paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer

ACS Applied Materials and Interfaces

Volumn 8, Issue 7, 2016, Pages 4368-4377

  Wang, Ning ^a   He, Tao ^a   Shen, Yangmei ^b   Song, Linjiang ^a   Li, Ling ^a   Yang, Xi ^a   Li, Xia ^a   Pang, Mengru ^a   Su, Weijun ^c   Liu, Xinyu ^a   Wu, Qinjie ^a   Gong, Changyang ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c NANKAI UNIVERSITY   (China)

Author keywords

codelivery; micelles; multidrug resistant; ovarian cancer; paclitaxel; tacrolimus

Indexed keywords

CELL DEATH; CELL SIGNALING; CHEMOTHERAPY; DISEASES; FUNCTIONAL POLYMERS; MICELLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS;

CO DELIVERIES; MULTIDRUG RESISTANTS; OVARIAN CANCERS; PACLITAXEL; TACROLIMUS;

DRUG DELIVERY;

MACROGOL DERIVATIVE; METHOXY POLY(ETHYLENE GLYCOL-CO-EPSILON-CAPROLACTONE); MICELLE; PACLITAXEL; POLYESTER; TACROLIMUS;

APOPTOSIS; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; GENETICS; HUMAN; MICELLE; OVARIAN NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICELLES; OVARIAN NEOPLASMS; PACLITAXEL; POLYESTERS; POLYETHYLENE GLYCOLS; TACROLIMUS;

EID: 84962236869     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.2c00479     Document Type: Erratum

References (43)

1. Siegel, R.; Ma, J.; Zou, Z.; Jemal, A. Cancer Statistics, 2014 Ca-Cancer J. Clin. 2014, 64, 9-29 10.3322/caac.21208
2. Deppe, G.; Baumann, P. Advances in Ovarian Cancer Chemotherapy Curr. Opin. Oncol. 2000, 12, 481-491 10.1097/00001622-200009000-00016
3. Bebawy, M.; Combes, V.; Lee, E.; Jaiswal, R.; Gong, J.; Bonhoure, A.; Grau, G. E. Membrane Microparticles Mediate Transfer of P-Glycoprotein to Drug Sensitive Cancer Cells Leukemia 2009, 23, 1643-1649 10.1038/leu.2009.76
4. Patel, N. R.; Rathi, A.; Mongayt, D.; Torchilin, V. P. Reversal of Multidrug Resistance by Co-Delivery of Tariquidar (XR9576) and Paclitaxel using Long-Circulating Liposomes Int. J. Pharm. 2011, 416, 296-299 10.1016/j.ijpharm.2011.05.082
5. Wong, H. L.; Bendayan, R.; Rauth, A. M.; Wu, X. Y. Simultaneous Delivery of Doxorubicin and GG918 (Elacridar) by New Polymer-Lipid Hybrid Nanoparticles (PLN) for Enhanced Mreatment of Multidrug-Resistant Breast Cancer J. Controlled Release 2006, 116, 275-284 10.1016/j.jconrel.2006.09.007
6. Gao, B.; Russell, A.; Beesley, J.; Chen, X. Q.; Healey, S.; Henderson, M.; Wong, M.; Emmanuel, C.; Galletta, L.; Johnatty, S. E.; Bowtell, D.; Haber, M.; Norris, M.; Harnett, P.; Chenevix-Trench, G.; Balleine, R. L.; deFazio, A. et al. Paclitaxel Sensitivity in Relation to ABCB1 Expression, Efflux and Single Nucleotide Polymorphisms in Ovarian Cancer Sci. Rep. 2014, 4, 4669 10.1038/srep04669
7. Trock, B. J.; Leonessa, F.; Clarke, R. Multidrug Resistance in Breast Cancer: a Meta-Analysis of MDR1/gp170 Expression and Its Possible Functional Significance J. Natl. Cancer Inst. 1997, 89, 917-931 10.1093/jnci/89.13.917
8. Gong, C.; Xie, Y.; Wu, Q.; Wang, Y.; Deng, S.; Xiong, D.; Liu, L.; Xiang, M.; Qian, Z.; Wei, Y. Improving Anti-Tumor Activity with Polymeric Micelles Entrapping Paclitaxel in Pulmonary Carcinoma Nanoscale 2012, 4, 6004-6017 10.1039/c2nr31517c
9. Ganta, S.; Amiji, M. Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations to Overcome Multidrug Resistance in Tumor Cells Mol. Pharmaceutics 2009, 6, 928-939 10.1021/mp800240j
10. Wu, H.; Hait, W. N.; Yang, J. M. Small Interfering RNA-Induced Suppression of MDR1 (P-Glycoprotein) Restores Sensitivity to Multidrug-Resistant Cancer Cells Cancer Res. 2003, 63, 1515-1519
11. Arceci, R. J.; Stieglitz, K.; Bierer, B. E. Immunosuppressants FK506 and Rapamycin Function as Reversal Agents of the Multidrug Resistance Phenotype Blood 1992, 80, 1528-1536
12. Yokogawa, K.; Takahashi, M.; Tamai, I.; Konishi, H.; Nomura, M.; Moritani, S.; Miyamoto, K.; Tsuji, A. P-Glycoprotein-Dependent Disposition Kinetics of Tacrolimus: Studies in mdr1a Knockout Mice Pharm. Res. 1999, 16, 1213-1218 10.1023/A:1018993312773
13. Naito, M.; Oh-hara, T.; Yamazaki, A.; Danki, T.; Tsuruo, T. Reversal of Multidrug Resistance by an Immunosuppressive Agent FK-506 Cancer Chemother. Pharmacol. 1992, 29, 195-200 10.1007/BF00686252
14. Saeki, T.; Ueda, K.; Tanigawara, Y.; Hori, R.; Komano, T. Human P-Glycoprotein Transports Cyclosporin A and FK506 J. Biol. Chem. 1993, 268, 6077-6080
15. Tamura, S.; Ohike, A.; Ibuki, R.; Amidon, G. L.; Yamashita, S. Tacrolimus is a Class II Low-Solubility High-Permeability Drug: the Effect of P-Glycoprotein Efflux on Regional Permeability of Tacrolimus in Rats J. Pharm. Sci. 2002, 91, 719-729 10.1002/jps.10041
16. Lee, C. H. Reversing Agents for ATP-Binding Cassette Drug Transporters Methods Mol. Biol. 2010, 596, 325-340 10.1007/978-1-60761-416-6-14
17. Yang, S.; Gursoy, R. N.; Lambert, G.; Benita, S. Enhanced Oral Absorption of Paclitaxel in a Novel Self-Microemulsifying Drug Delivery System with or without Concomitant Use of P-Glycoprotein Inhibitors Pharm. Res. 2004, 21, 261-270 10.1023/B:PHAM.0000016238.44452.f1
18. Egner, R.; Rosenthal, F. E.; Kralli, A.; Sanglard, D.; Kuchler, K. Genetic Separation of FK506 Susceptibility and Drug Transport in the Yeast Pdr5 ATP-Binding Cassette Multidrug Resistance Transporter Mol. Biol. Cell 1998, 9, 523-543 10.1091/mbc.9.2.523
19. Thipparaboina, R.; Chavan, R. B.; Kumar, D.; Modugula, S.; Shastri, N. R. Micellar Carriers for the Delivery of Multiple Therapeutic Agents Colloids Surf., B 2015, 135, 291-308 10.1016/j.colsurfb.2015.07.046
20. Pawarode, A.; Shukla, S.; Minderman, H.; Fricke, S. M.; Pinder, E. M.; O'Loughlin, K. L.; Ambudkar, S. V.; Baer, M. R. Differential Effects of the Immunosuppressive Agents Cyclosporin A, Tacrolimus and Sirolimus on Drug Transport by Multidrug Resistance Proteins Cancer Chemother. Pharmacol. 2007, 60, 179-188 10.1007/s00280-006-0357-8
21. Wu, Q.; Deng, S.; Li, L.; Sun, L.; Yang, X.; Liu, X.; Liu, L.; Qian, Z.; Wei, Y.; Gong, C. Biodegradable Polymeric Micelle-Encapsulated Quercetin Suppresses Tumor Growth and Metastasis in Both Transgenic Zebrafish and Mouse Models Nanoscale 2013, 5, 12480-12493 10.1039/c3nr04651f
22. Gou, M.; Zheng, X.; Men, K.; Zhang, J.; Wang, B.; Lv, L.; Wang, X.; Zhao, Y.; Luo, F.; Chen, L.; Zhao, X.; Wei, Y.; Qian, Z. Self-Assembled Hydrophobic Honokiol Loaded MPEG-PCL Diblock Copolymer Micelles Pharm. Res. 2009, 26, 2164-2173 10.1007/s11095-009-9929-8
23. Gong, C.; Wang, C.; Wang, Y.; Wu, Q.; Zhang, D.; Luo, F.; Qian, Z. Efficient Inhibition of Colorectal Peritoneal Carcinomatosis by Drug Loaded Micelles in Thermosensitive Hydrogel Composites Nanoscale 2012, 4, 3095-3104 10.1039/c2nr30278k
24. Zhang, N.; Liu, S.; Wang, N.; Deng, S.; Song, L.; Wu, Q.; Liu, L.; Su, W.; Wei, Y.; Xie, Y.; Gong, C. Biodegradable Polymeric Micelles Encapsulated JK184 Suppress Tumor Growth through Inhibiting Hedgehog Signaling Pathway Nanoscale 2015, 7, 2609-2624 10.1039/C4NR06300G
25. Cao, H.; Wang, Y.; He, X.; Zhang, Z.; Yin, Q.; Chen, Y.; Yu, H.; Huang, Y.; Chen, L.; Xu, M.; Gu, W.; Li, Y. Codelivery of Sorafenib and Curcumin by Directed Self-Assembled Nanoparticles Enhances Therapeutic Effect on Hepatocellular Carcinoma Mol. Pharmaceutics 2015, 12, 922-931 10.1021/mp500755j
26. Han, M.; Yu, X.; Guo, Y.; Wang, Y.; Kuang, H.; Wang, X. Honokiol Nanosuspensions: Preparation, Increased Oral Bioavailability and Dramatically Enhanced Biodistribution in the Cardio-Cerebro-Vascular System Colloids Surf., B 2014, 116, 114-120 10.1016/j.colsurfb.2013.12.056
27. Tian, B.; Ding, Y.; Han, J.; Zhang, J.; Han, Y.; Han, J. N-Acetyl-D-Glucosamine Decorated Polymeric Nanoparticles for Targeted Delivery of Doxorubicin: Synthesis, Characterization and in Vitro Evaluation Colloids Surf., B 2015, 130, 246-254 10.1016/j.colsurfb.2015.04.019
28. Gong, C.; Deng, S.; Wu, Q.; Xiang, M.; Wei, X.; Li, L.; Gao, X.; Wang, B.; Sun, L.; Chen, Y.; Li, Y.; Liu, L.; Qian, Z.; Wei, Y. Improving Antiangiogenesis and Anti-Tumor Activity of Curcumin by Biodegradable Polymeric Micelles Biomaterials 2013, 34, 1413-1432 10.1016/j.biomaterials.2012.10.068
29. Wang, F.; Shen, Y.; Xu, X.; Lv, L.; Li, Y.; Liu, J.; Li, M.; Guo, A.; Guo, S.; Jin, F. Selective Tissue Distribution and Long Circulation Endowed by Paclitaxel Loaded PEGylated Poly(Epsilon-Caprolactone-Co-L-Lactide) Micelles Leading to Improved Anti-Tumor Effects and Low Systematic Toxicity Int. J. Pharm. 2013, 456, 101-112 10.1016/j.ijpharm.2013.08.008
30. Zhao, D.; Li, B.; Han, J.; Yang, Y.; Zhang, X.; Wu, G. PH Responsive Polypeptide Based Polymeric Micelles for Anticancer Drug Delivery J. Biomed. Mater. Res., Part A 2015, 103, 3045-3053 10.1002/jbm.a.35434
31. Wang, Y.; Wang, C.; Fu, S.; Liu, Q.; Dou, D.; Lv, H.; Fan, M.; Guo, G.; Luo, F.; Qian, Z. Preparation of Tacrolimus Loaded Micelles Based on Poly(Varepsilon-Caprolactone)-Poly(Ethylene Glycol)-Poly(Varepsilon-Caprolactone) Int. J. Pharm. 2011, 407, 184-189 10.1016/j.ijpharm.2011.01.018
32. Gou, M.; Zheng, X.; Men, K.; Zhang, J.; Zheng, L.; Wang, X.; Luo, F.; Zhao, Y.; Zhao, X.; Wei, Y.; Qian, Z. Poly(Epsilon-Caprolactone)/Poly(Ethylene Glycol)/Poly(Epsilon-Caprolactone) Nanoparticles: Preparation, Characterization, and Application in Doxorubicin Delivery J. Phys. Chem. B 2009, 113, 12928-12933 10.1021/jp905781g
33. Gong, C.; Wei, X.; Wang, X.; Wang, Y.; Guo, G.; Mao, Y.; Luo, F.; Qian, Z. Biodegradable Self-Assembled PEG-PCL-PEG Micelles for Hydrophobic Honokiol Delivery: I. Preparation and Characterization Nanotechnology 2010, 21, 215103 10.1088/0957-4484/21/21/215103
34. Shabbits, J. A.; Krishna, R.; Mayer, L. D. Molecular and Pharmacological Strategies to Overcome Multidrug Resistance Expert Rev. Anticancer Ther. 2001, 1, 585-594 10.1586/14737140.1.4.585
35. Fukuda, Y.; Schuetz, J. D. ABC Transporters and Their Role in Nucleoside and Nucleotide Drug Resistance Biochem. Pharmacol. 2012, 83, 1073-1083 10.1016/j.bcp.2011.12.042
36. Gong, M. Q.; Wu, J. L.; Chen, B.; Zhuo, R. X.; Cheng, S. X. Self-Assembled Polymer/Inorganic Hybrid Nanovesicles for Multiple Drug Delivery to Overcome Drug Resistance in Cancer Chemotherapy Langmuir 2015, 31, 5115-5122 10.1021/acs.langmuir.5b00542
37. Farokhzad, O. C.; Langer, R. Impact of Nanotechnology on Drug Delivery ACS Nano 2009, 3, 16-20 10.1021/nn900002m
38. Whitehead, K. A.; Langer, R.; Anderson, D. G. Knocking Down Barriers: Advances in siRNA Delivery Nat. Rev. Drug Discovery 2009, 8, 129-138 10.1038/nrd2742
39. Woodcock, J.; Griffin, J. P.; Behrman, R. E. Development of Novel Combination Therapies N. Engl. J. Med. 2011, 364, 985-987 10.1056/NEJMp1101548
40. Takeguchi, N.; Ichimura, K.; Koike, M.; Matsui, W.; Kashiwagura, T.; Kawahara, K. Inhibition of the Multidrug Efflux Pump in Isolated Hepatocyte Couplets by Immunosuppressants FK506 and Cyclosporine Transplantation 1993, 55, 646-650 10.1097/00007890-199303000-00033
41. Oda, K.; Nemoto, H.; Nagasaka, Y.; Kawamura, A.; Usui, T. In Vitro Experimental System for Evaluating Inhibitory Effect of Investigational Drugs on P-Glycoprotein-Mediated Transcellular Transport of Tacrolimus (FK506) Biopharm. Drug Dispos. 2014, 35, 135-144 10.1002/bdd.1876
42. Wu, J.; Lu, Y.; Lee, A.; Pan, X.; Yang, X.; Zhao, X.; Lee, R. J. Reversal of Multidrug Resistance by Transferrin-Conjugated Liposomes Co-Encapsulating Doxorubicin and Verapamil J. Pharm. Pharm. Sci. 2007, 10, 350-357
43. Di Maio, M.; Chiodini, P.; Georgoulias, V.; Hatzidaki, D.; Takeda, K.; Wachters, F. M.; Gebbia, V.; Smit, E. F.; Morabito, A.; Gallo, C.; Perrone, F.; Gridelli, C. Meta-Analysis of Single-Agent Chemotherapy Compared with Combination Chemotherapy as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer J. Clin. Oncol. 2009, 27, 1836-1843 10.1200/JCO.2008.17.5844